⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Barclays BARC.L

United Kingdom Financial Services
6.4/10
AI Analyst score
4.64 GBP
Last price at analysis date · analyst target 5.73 (+23.6%)
🛒 Where to buy BARC.LPartner brokers · UK (LSE) · sample 200.00 € orderUK (LSE)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold positions; valuation is attractive but growth is already reflected in the scores.

Barclays is a British universal bank with global operations in retail banking, credit cards, and investment banking. Barclays presents adequate financial health (ROE 10.09%) and exceptional quality (operating margin 42.95%), with solid growth (earnings +44.60%) and an attractive valuation (P/E 9.66).

Financial health
3.8
Quality / Moat
9.1
Valuation
7.1
Growth
8.3
Dividend
3.2
Momentum
6.0
Risk & Context
7.1

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E9.66
Fwd P/E7.21
EV/EBITDAN/D
P/B0.95
P/S2.20
PEG0.95
Market cap62.02 B GBP
Enterprise value74.06 B GBP
🏰 Quality and moat
ROIC (approx.)1.4%
Gross margin0.00%
FCF conversionN/D
Operating margin42.95%
📈 Profitability and margins
ROE10.09%
ROA0.47%
Net margin27.87%
FCFN/D
FCF yieldN/D
🏦 Solvency and liquidity
Total debt782.35 B GBP
Net debt10.69 B GBP
Cash771.66 B GBP
EBITDAN/D
Net debt / EBITDAN/D
D/EN/D
Current ratioN/D
Quick ratioN/D
🚀 Growth
Revenue growth15.60%
Earnings growth44.60%
EPS (TTM)0.48 GBP
EPS (Fwd)0.64 GBP
💰 Dividend and risk
Dividend yield0.03%
Payout17.8%
Beta0.87
Analyst consensusBuy (17)
Target price5.73 GBP
52-week range3.54 GBP – 5.38 GBP
⚠️ Main risk: The main risk is exposure to global capital markets and a potential economic slowdown, which could affect credit demand and investment banking activity.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Barclays is a British universal bank with global operations in retail banking, credit cards, and investment banking. Barclays presents adequate financial health (ROE 10.09%) and exceptional quality (operating margin 42.95%), with solid growth (earnings +44.60%) and an attractive valuation (P/E 9.66).

Score by category

CategoryScore
Financial health3.8
Quality / Moat9.1
Valuation7.1
Growth8.3
Dividend3.2
Momentum6.0
Risk & Context7.1

OVERALL SCORE: 6.4/10

Context and risks

No specific regulatory, geopolitical, or business model risks beyond those already considered in the base risk. The macro context of diverging interest rates between the Fed and the ECB is considered neutral for Barclays, as its business is global and benefits from both scenarios.

News considered in the analysis

  • Barclays sees lasting labor-market pressures as immigration slows, population ages — Comentario macroeconómico general sin impacto directo en los fundamentales de Barclays.
  • Humana (HUM) Jumped, But What Is Drawing Fresh Attention Now? — Noticia sobre Humana, un competidor en el sector salud, sin relevancia para Barclays.
  • Genel Energy (LSE:GENL) Stock Gets Fair Value Boost As Growth And Margin Forecasts Rise — Noticia sobre Genel Energy, empresa del sector energético, sin impacto en Barclays.
  • UK PM Burnham to set out economic vision as inflation, Iran war pose challenges — Noticia política y macroeconómica general del Reino Unido, sin impacto directo y cuantificable en Barclays.
  • Humana Stock Jumps. Why It Could Be a Big Winner in Next Medicare Star Ratings. — Noticia sobre Humana, sin relevancia para Barclays.

Verdict: Hold positions; valuation is attractive but growth is already reflected in the scores.

Main risk: The main risk is exposure to global capital markets and a potential economic slowdown, which could affect credit demand and investment banking activity.

Other Financial Services companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.